Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy

Objective: To guide clinicians in selecting the “next line” selective serotonin reuptake inhibitor (SSRI) for adolescents with treatment-resistant major depressive disorder, we sought to compare response rates among SSRIs in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Child Adolesc Psychopharmacol
Autores principales: Strawn, Jeffrey R., Mills, Jeffrey A., Croarkin, Paul E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Brief Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534091/
https://ncbi.nlm.nih.gov/pubmed/30810350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2018.0145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares